Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X4025
Healthcare Facilities & Services
OTC Markets Traded|
Delayed
OTC Markets
13:17:24 2026-11-04 EST
|
5-day change | 1st Jan Change | ||
| 5.720 USD | +5.10% |
|
+15.56% | -7.01% |
| Market Cap | 30.16M 26.88M 24.65M 22.4M 42.11M 2.85B 43.07M 295M 118M 1.51B 113M 111M 4.78B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 28.84M 25.7M 23.57M 21.42M 40.26M 2.73B 41.18M 282M 113M 1.44B 108M 106M 4.57B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
8.77% | Yield 2024 * |
-
| Yield 2025 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| IDXG | Delayed | |
Börse Stuttgart
| PF4 | Delayed | |
|
Boerse Muenchen
| PF4 | Real-time |
| 1 day | +5.10% | ||
| 1 week | +15.56% | ||
| Current month | +2.28% | ||
| 1 month | -4.67% | ||
| 3 months | -29.82% | ||
| 6 months | -42.80% | ||
| Current year | -7.01% |
| 1 week | 5.05 |  | 5.72 |
| 1 month | 4.95 | | 6.5 |
| Current year | 4.95 | | 12 |
| 1 year | 4.03 | | 12 |
| 3 years | 2.22 | | 17.7 |
| 5 years | 2.22 | | 45 |
| 10 years | 2.22 | | 990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 | Free | Director | 69,252 | 0.2501% | ||
| 8/20/26 | Exercice | Chief Financial Officer | 1,385,045 | 5.0015% | ||
| 8/20/26 | Free | Director | 69,252 | 0.2501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.10% | +15.56% | +14.40% | +20.42% | 30.16M | |
| -11.72% | -10.72% | +2.86% | +12.99% | 117B | |
| +9.89% | +9.81% | +7.84% | +120.19% | 96.69B | |
| -0.63% | -8.98% | +96.65% | +796.31% | 56.02B | |
| +9.00% | +1.61% | -4.61% | +85.70% | 30.77B | |
| +3.75% | +1.98% | +45.59% | +75.32% | 28.74B | |
| +3.12% | +3.81% | +43.22% | +90.44% | 27.18B | |
| +8.56% | +7.62% | +39.11% | +429.15% | 21.23B | |
| +2.11% | -3.44% | -20.07% | -16.77% | 19.49B | |
| +0.26% | -0.77% | -6.83% | +29.88% | 16.82B | |
| Average | +2.89% | +0.27% | +21.82% | +164.36% | 41.39B | |
| Weighted average by Cap. | +0.55% | +0.56% | +22.16% | +179.51% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 41.82M 38.35M 34.85M 65.51M 4.43B 67.01M 458M 184M 2.35B 176M 172M 7.44B | 38.73M 34.51M 31.65M 28.76M 54.07M 3.66B 55.3M 378M 152M 1.94B 145M 142M 6.14B |
| Net income | 6.7M 5.97M 5.48M 4.98M 9.36M 633M 9.57M 65.46M 26.24M 335M 25.16M 24.62M 1.06B | 24.58M 21.9M 20.08M 18.25M 34.31M 2.32B 35.09M 240M 96.22M 1.23B 92.24M 90.27M 3.89B |
| Net Debt | 4.4M 3.92M 3.59M 3.26M 6.14M 415M 6.28M 42.93M 17.21M 220M 16.5M 16.14M 696M | -1.32M -1.18M -1.08M -982K -1.85M -125M -1.89M -12.91M -5.18M -66.13M -4.96M -4.86M -209M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-04 | US$5.720 | +5.10% | 2,372 |
| 26-11-02 | US$5.443 | -2.68% | 204 |
| 26-10-30 | US$5.593 | -2.23% | 502 |
| 26-10-29 | US$5.720 | +15.56% | 5,107 |
| 26-10-28 | US$4.950 | -10.00% | 1,880 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
